The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019
Open accessAbstract
Aims: To evaluate current status of prostate cancer incidence and mortality worldwide, and compare the global trends of incidence and mortality in the past two decades and in the most recent period. Methods: Data on the incidence and mortality of prostate cancer for 174 countries in 2020 were obtained from the GLOBOCAN 2020 database, and associations with the human development index (HDI) were evaluated. Data for trend analyses in 89 countries from 2000 to 2019 were retrieved from the Global Burden of Disease 2019 platform. Age standardized incidence rate (ASIR) and mortality rate (ASMR) were calculated by using the Segi's population. The average annual percent changes (AAPC) of ASIRs and ASMRs were evaluated by joinpoint regression analysis. Results: A total of 1 414 259 new cases of prostate cancer and 375 304 related deaths were reported in 2020 globally. HDI was positively correlated with ASIRs (P < 0.001) and negatively correlated with ASMRs (P < 0.001). In the past two decades, ASIRs have been increasing in 65 countries, stable in 15 countries and decreasing in 9 countries, and ASMRs have been increasing in 19 countries, stable in 25 countries and decreasing in 45 countries, respectively. In the most recent period, 44 countries have increasing ASIRs, and 32 countries have decreasing ASMRs, respectively. For instance, in the United States of America, the AAPC of ASIRs significantly decreased by 0.62% and ASMRs significantly decreased by 1.22% from 2000 to 2019, while the AAPC from 2015 to 2019 significantly increased by 0.49% for ASIRs and significantly increased by 0.48% for ASMRs. Conclusion: The magnitude of increasing incidence and decreasing mortality of prostate cancer is attenuated in the recent period. Further study is needed to analyze the absolute effect of risk factors, PSA screening and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Self-citationPermutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Mottet, N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.042 · Cited by 2,802
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Klein, E. A., Thompson, I. M., Tangen, C. M., Crowley, J. J., Lucia, M. S., Goodman, P. J., Minasian, L. M., Ford, L. G., Parnes, H. L., Gaziano, J. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1437 · Cited by 1,787
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Zappa, M., Nelen, V., Kwiatkowski, M., Lujan, M., Määttänen, L., Lilja, H., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60525-0 · Cited by 1,566
Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30127-x · Cited by 1,546
International Variation in Prostate Cancer Incidence and Mortality Rates
Center, M. M., Jemal, A., Lortet-Tieulent, J., Ward, E., Ferlay, J., Brawley, O., & Bray, F. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.054 · Cited by 1,521 · cited 1×
“Advancing age, black race, and family history are wellestablished risk factors for prostate cancer (3).”
BackgroundScreening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Grossman, D. C., Curry, S. J., Owens, D. K., Bibbins-Domingo, K., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Ebell, M., Epling, J. W., et al. (2018) · JAMA · doi:10.1001/jama.2018.3710 · Cited by 1,436
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F., & Jemal, A. (2020) · European Urology · doi:10.1016/j.eururo.2019.08.005 · Cited by 1,364
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Isaacs, C., Kvale, P. A., Reding, D. J., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr500 · Cited by 1,121
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Wolf, A. M. D., Wender, R. C., Etzioni, R. B., Thompson, I. M., D'Amico, A. V., Volk, R. J., Brooks, D. D., Dash, C., Guessous, I., Andrews, K., et al. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20066 · Cited by 965
Overdiagnosis and Overtreatment of Prostate Cancer
Loeb, S., Bjurlin, M. A., Nicholson, J., Tammela, T. L., Penson, D. F., Carter, H. B., Carroll, P., & Etzioni, R. (2014) · European Urology · doi:10.1016/j.eururo.2013.12.062 · Cited by 964
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Study, T. P., Schumacher, F. R., (APCB), A. P. C. B., Study, T. I., Canary PASS Investigators, Breast and Prostate Cancer Cohort Consortium (BPC3), The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, (CAPS), C. O. T. P. I. S., Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS), The Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium, et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0142-8 · Cited by 902
The Epidemiology of Prostate Cancer
Pernar, C. H., Ebot, E. M., Wilson, K. M., & Mucci, L. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030361 · Cited by 773
Obesity and Prostate Cancer: Weighing the Evidence
Allott, E. H., Masko, E. M., & Freedland, S. J. (2013) · European Urology · doi:10.1016/j.eururo.2012.11.013 · Cited by 601
Health policy and public health implications of obesity in China
Wang, Y., Zhao, L., Gao, L., Pan, A., & Xue, H. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00118-2 · Cited by 526
Self-citationScreening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00008 · Cited by 505
Epidemiology of prostate cancer in Asian countries
Kimura, T., & Egawa, S. (2018) · International Journal of Urology · doi:10.1111/iju.13593 · Cited by 411
A genomic and epigenomic atlas of prostate cancer in Asian populations
Li, J., Xu, C., Lee, H. J., Ren, S., Zi, X., Zhang, Z., Wang, H., Yu, Y., Yang, C., Gao, X., et al. (2020) · Nature · doi:10.1038/s41586-020-2135-x · Cited by 344
Self-citationQaseem, A., Barry, M. J., Denberg, T. D., Owens, D. K., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-10-201305210-00633 · Cited by 287
Epidemiology and genomics of prostate cancer in Asian men
Zhu, Y., Mo, M., Wei, Y., Wu, J., Pan, J., Freedland, S. J., Zheng, Y., & Ye, D. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00442-8 · Cited by 287
Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study
Collin, S. M., Martin, R. M., Metcalfe, C., Gunnell, D., Albertsen, P. C., Neal, D., Hamdy, F., Stephens, P., Lane, J. A., Moore, R., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70104-9 · Cited by 272
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
Tsodikov, A., Gulati, R., Heijnsdijk, E. A. M., Pinsky, P. F., Moss, S. M., Qiu, S., de Carvalho, T. M., Hugosson, J., Berg, C. D., Auvinen, A., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2586 · Cited by 251
The Proteogenomic Landscape of Curable Prostate Cancer
Sinha, A., Huang, V., Livingstone, J., Wang, J., Fox, N. S., Kurganovs, N., Ignatchenko, V., Fritsch, K., Donmez, N., Heisler, L. E., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.005 · Cited by 248
Wu, L., Yang, Y., Guo, X., Shu, X.-O., Cai, Q., Shu, X., Li, B., Tao, R., Wu, C., Nikas, J. B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17673-9 · Cited by 244
Negoita, S., Feuer, E. J., Mariotto, A., Cronin, K. A., Petkov, V. I., Hussey, S. K., Benard, V., Henley, S. J., Anderson, R. N., Fedewa, S., et al. (2018) · Cancer · doi:10.1002/cncr.31549 · Cited by 239
Mattiuzzi, C., & Lippi, G. (2020) · European Journal of Public Health · doi:10.1093/eurpub/ckz216 · Cited by 215
Drazer, M. W., Huo, D., & Eggener, S. E. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6532 · Cited by 194
Prostate cancer progression and mortality: a review of diet and lifestyle factors
Peisch, S. F., Van Blarigan, E. L., Chan, J. M., Stampfer, M. J., & Kenfield, S. A. (2017) · World Journal of Urology · doi:10.1007/s00345-016-1914-3 · Cited by 188
Jemal, A., Culp, M. B., Ma, J., Islami, F., & Fedewa, S. A. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa068 · Cited by 167
Basch, E., Oliver, T. K., Vickers, A. J., Thompson, I. M., Kantoff, P. W., Parnes, H. L., Loblaw, D. A., Roth, B. J., Williams, J. K., & Nam, R. K. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.3441 · Cited by 156
Kakehi, Y., Sugimoto, M., & Taoka, R. (2017) · International Journal of Urology · doi:10.1111/iju.13380 · Cited by 144
Zhai, Z., Zheng, Y., Li, N., Deng, Y., Zhou, L., Tian, T., Yang, S., Hao, Q., Song, D., Wu, Y., et al. (2020) · Cancer · doi:10.1002/cncr.32733 · Cited by 132
Self-citationProstate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel
Mahal, B. A. V., Gerke, T. A., Awasthi, S., Soule, H. R., Simons, J. W., Miyahira, A. K., Halabi, S., George, D. J., Platz, E. A., Mucci, L. A., et al. (2021) · European Urology Oncology · doi:10.1016/j.euo.2021.07.006 · Cited by 107
The incidence and mortality of prostate cancer and its relationship with development in Asia
Pakzad, R., Mohammadian-Hafshejani, A., Ghoncheh, M., Pakzad, I., & Salehiniya, H. (2015) · Prostate International · doi:10.1016/j.prnil.2015.09.001 · Cited by 97
Prostate cancer screening in Europe and Asia
Zhang, K., Bangma, C. H., & Roobol, M. J. (2016) · Asian journal of urology · doi:10.1016/j.ajur.2016.08.010 · Cited by 91
Reconsidering the Trade-offs of Prostate Cancer Screening
Shoag, J. E., Nyame, Y. A., Gulati, R., Etzioni, R., & Hu, J. C. (2020) · New England Journal of Medicine · doi:10.1056/nejmsb2000250 · Cited by 83
Kensler, K., Pernar, C. H., Mahal, B., Nguyen, P., Trinh, Q., Kibel, A., & Rebbeck, T. (2020) · Journal of the National Cancer Institute · doi:10.1093/jnci/djaa171 · Cited by 82
Cai, H., Xu, Z., Xu, T., Yu, B., & Zou, Q. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2582 · Cited by 80
Canadian Urological Association recommendations on prostate cancer screening and early diagnosis
Rendon, R. A., Mason, R. J., Marzouk, K., Finelli, A., Fred Saad, C., So, A., Violette, P. D., & Breau, R. H. (2017) · Canadian Urological Association Journal · doi:10.5489/cuaj.4888 · Cited by 74
Luo, C., Li, N., Lu, B., Cai, J., Lu, M., Zhang, Y., Chen, H., & Dai, M. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001814 · Cited by 71
Self-citationLu, B., Li, N., Luo, C., Cai, J., Lu, M., Zhang, Y., Chen, H., & Dai, M. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001619 · Cited by 70
Self-citationZeigler-Johnson, C. M., Spangler, E., Jalloh, M., Gueye, S. M., Rennert, H., & Rebbeck, T. R. (2008) · PubMed · Cited by 68
Sharma, R. (2019) · The EPMA Journal · doi:10.1007/s13167-019-00169-y · Cited by 44
Taioli, E., Flores‐Obando, R. E., Agalliu, I., Blanchet, P., Bunker, C. H., Ferrell, R. E., Jackson, M. D., Kidd, L. R., Kolb, S., Lavender, N., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr119 · Cited by 36
Zargar, H. S., van den Bergh, R. C. N., Moon, D., Lawrentschuk, N., Costello, A., & Murphy, D. G. (2016) · British Journal of Urology · doi:10.1111/bju.13602 · Cited by 29
Goldenberg, M. G., Skeldon, S., Nayan, M., et al. (2017) · Canadian Urological Association Journal · doi:10.5489/cuaj.4486 · Cited by 18
Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer
Nyame, Y. A., Gulati, R., Tsodikov, A., Gore, J. L., & Etzioni, R. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa098 · Cited by 18
Reiter–Brennan, C., Dzaye, O. D. A., Al-Mallah, M. H., Dardari, Z., Brawner, C. A., Lamerato, L. E., Keteyian, S. J., Ehrman, J. K., Blaha, M. J., Visvanathan, K., et al. (2021) · Cancer · doi:10.1002/cncr.33426 · Cited by 15
Cited by
The Lancet Commission on prostate cancer: planning for the surge in cases
James, N. D., Tannock, I., N'Dow, J., Feng, F., Gillessen, S., Ali, S. A., Trujillo, B., Al-Lazikani, B., Attard, G., Bray, F., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00651-2 · Cited by 738
Gibson, D., Jackson, S., Shanmugasundaram, R., Seth, I., Siu, A., Ahmadi, N., Kam, J., Mehan, N., Thanigasalam, R., Jeffery, N., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/55939 · Cited by 122
Quality by design empowered preparation of itraconazole albumin nanoparticles for prostate cancer
Shah, S., Famta, P., Sharma, A., Kumar, R., Pandey, G., Vambhurkar, G., Srinivasarao, D. A., Shinde, A., Prasad, S. B., Asthana, A., et al. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01592-z · Cited by 12
Metadata
- Authors
- Wang, L., Lu, B., He, M., Wang, Y., Wang, Z., & Du, L.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2022-02-16
- Volume
- 10
- Pages
- 811044-811044
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W4213089453
- Cited by
- 646
- References
- 52
- FWCI
- 51.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.